⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10829722 | 0.69 | — | — | |
| SCHEMBL5780961 | 0.69 | — | — | |
| SCHEMBL20158602 | 0.67 | — | — | |
| SCHEMBL13162788 | 0.67 | — | — | |
| SCHEMBL10296613 | 0.63 | — | — | |
| SCHEMBL19175616 | 0.60 | — | — | |
| SCHEMBL10296550 | 0.59 | — | — | |
| SCHEMBL24200954 | 0.59 | — | — | |
| SCHEMBL6189700 | 0.56 | — | — | |
| SCHEMBL12628156 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110023371-A | Perfusion materia, insulating materials and application thereof | 西门子股份公司 | 2019-07-16 | — | — | CN | claimed |
| EP-0115248-A1 | Substituted 5H-pyrimido(5,4-b)indoles | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-08-08 | — | — | EP | claimed |
| EP-4026562-A1 | CHRONIC KIDNEY DISEASE TREATMENT OR PREVENTION METHOD | Japan Tobacco Inc. (JP) | 2022-07-13 | — | — | EP | disclosed |
| EP-3424905-B1 | HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2021-08-04 | — | — | EP | disclosed |
| WO-2021143246-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND FUSED RING-BASED AROMATIC AMINE COMPOUNDS | 广州华睿光电材料有限公司 | 2021-07-22 | — | — | WO | disclosed |
| WO-2021093377-A1 | ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING MATERIAL OF LIGHT EXTRACTION LAYER | 广州华睿光电材料有限公司 | 2021-05-20 | — | — | WO | disclosed |
| EP-3798214-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2021-03-31 | — | — | EP | disclosed |
| US-10662189-B2 | PDE4 inhibitor | Shijiazhuang Sagacity New Drug Development Co., Ltd. (CN) | 2020-05-26 | — | — | US | disclosed |
| WO-2020041301-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2020-02-27 | — | — | WO | disclosed |
| CN-110023371-A | Perfusion materia, insulating materials and application thereof | 西门子股份公司 | 2019-07-16 | — | — | CN | disclosed |
| EP-2793311-B1 | METAL COMPLEX DYE, PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE SOLUTION, AND COMPOUND | FUJIFILM CORP (JP) | 2019-06-19 | — | — | EP | disclosed |
| US-20120172376-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | ABBOTT GMBH & CO. KG (DE) | 2012-07-05 | — | — | US | disclosed |
| EP-2094643-B1 | N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES | BRISTOL MYERS SQUIBB CO (US) | 2012-02-29 | — | — | EP | disclosed |
| WO-2012003190-A1 | RIMINOPHENAZINES WITH 2-(HETEROARYL)AMINO SUBSTITUENTS AND THEIR ANTI-MICROBIAL ACTIVITY | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (US) | 2012-01-05 | — | — | WO | disclosed |
| EP-1760110-B1 | Polybenzoxazine-based compound, electrolyte membrane including the same, and fuel cell employing the electrolyte membrane | SAMSUNG SDI CO LTD (KR) | 2011-11-02 | — | — | EP | disclosed |
| EP-2055706-B1 | Electrode and electrolyte membrane for fuel cell including a naphthoxazine based polymer and fuel cell using the electrode | SAMSUNG ELECTRONICS LTD (KR) | 2011-08-24 | — | — | EP | disclosed |
| WO-2011057804-A1 | METHOD FOR MECHANICALLY STABILIZING NITROGEN-CONTAINING POLYMERS | BASF SE (DE) | 2011-05-19 | — | — | WO | disclosed |
| EP-2131426-A1 | Electrode for Fuel Cell, Method of Manufacturing the Electrode, and Fuel Cell Employing the Electrode | Samsung Electronics Co., Ltd. (KR) | 2009-12-09 | — | — | EP | disclosed |
| US-20070264230-A1 | Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands | SCHERING CORPORATION | 2007-11-15 | — | — | US | disclosed |
| EP-0115248-A1 | Substituted 5H-pyrimido(5,4-b)indoles | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-08-08 | — | — | EP | disclosed |